Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyBlue Cross Blue Shield Nebraska keratoplasty Prior…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - NebraskaPolicy M.62

    MA Keratoplasty (Preauthorization Required)

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Nebraska Policy M.62 alerts

    Get alerted when Policy M.62 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity and preauthorization requirements for corneal collagen cross-linking, intrastromal corneal ring segments (INTACS), deep anterior lamellar keratoplasty (DALK), and full-thickness penetrating keratoplasty; applies to providers seeking coverage from Blue Cross Blue Shield - Nebraska.

    Policy Summary
    PayerBlue Cross Blue Shield - Nebraska
    PolicyMA Keratoplasty (Preauthorization Required)
    Policy CodePolicy M.62
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Last ReviewFeb 3, 2026
    Next Review DateFeb 3, 2027
    Key ActionObtain preauthorization and document diagnosis, objective progression measures, corneal thickness, prior therapies, and relevant procedure codes.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4procedure categories
    400CXL min thickness

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    450INTACS incision thickness
    21+INTACS min age
    6codes listed

    Coverage Criteria for Corneal Procedures

    Corneal Collagen Cross-Linking (CXL)

    Services may be considered reasonable and necessary when ALL of the following are met:

    CXL overall

    • Progression evidence: One or more of: keratoconus surgical treatment OR increase >=1.00 D in steepest keratometry OR increase in mean keratometry >=0.7 D OR thinning of corneal pachymetry >=10 microns OR reduction in uncorrected or best spectacle-corrected visual acuity by >1 linetimeframe: within preceding 12 months

      From policy text

    Intrastromal Corneal Ring Segments (INTACS)

    Services may be considered reasonable and necessary when ALL of the following are met:

    INTACS overall: Patient is >=21 years old AND diagnosis of keratoconus with progressive deterioration of vision AND inadequate vision correction with eyeglasses and contacts AND corneal transplantation is the ONLY alternative to intrastromal corneal ring segments for improving vision AND clear central cornea AND corneal thickness >=450 microns at the proposed incision siteage >=21; thickness >=450 microns

    All listed conditions required

    Deep Anterior Lamellar Keratoplasty (DALK)

    Services may be considered reasonable and necessary when ALL of the following are met:

    DALK overall: Disease involving the anterior 95% of corneal thickness with normal endothelium AND other treatment options (e.g., conventional CXL, INTACS) have failed or are not indicatedanterior 95% involvement

    Both conditions required

    Full Thickness Corneal Transplantation (Penetrating Keratoplasty)

    Services may be considered reasonable and necessary when:

    PK indications: Other treatment options (e.g., conventional CXL, INTACS, DALK) have failed or are not indicated; penetrating keratoplasty for conditions other than keratoconus (e.g., corneal degeneration/dystrophies, keratitis, trauma) is generally considered medically necessary and not subject to these specific criteriaN/A

    Policy reserves PK when alternatives fail or are not indicated; other indications are generally medically necessary

    Penetrating keratoplasty performed for indications other than keratoconus — for example, corneal degeneration or dystrophies, infectious or noninfectious keratitis, and traumatic corneal injury — is generally considered medically necessary and is not subject to the keratoconus-specific criteria in this policy. These non-keratoconus indications should be evaluated and authorized based on their clinical presentation and standard surgical indications rather than the progression thresholds listed for keratoconus-directed procedures.

    Procedures that do not meet the specific clinical criteria listed for each corneal intervention are generally considered not medically necessary. Examples include performing corneal collagen cross-linking (CXL) when documented progression criteria are absent or when corneal pachymetry is below the policy threshold of 400 microns. Similarly, INTACS, DALK, or penetrating keratoplasty requests that lack the required age, progression, thickness, anatomic, or prior-treatment findings may be denied as not meeting the policy’s reasonable-and-necessary conditions.

    Coding and Thresholds

    Covered CPT CodesCPTCovered
    0402TCOLLAGEN CROSS-LINKING OF CORNEA (INCLUDING REMOVAL OF THE CORNEAL EPITHELIUM AND INTRAOPERATIVE PACHYMETRY WHEN PERFORMED)
    65710KERATOPLASTY ANTERIOR LAMELLAR
    65730KERATOPLASTY PENETRATING (except in aphakia or pseudophakia)
    65750KERATOPLASTY PENETRATING (in aphakia)
    65755KERATOPLASTY PENETRATING (in pseudophakia)
    65756KERATOPLASTY ENDOTHELIAL
    65757BACKBENCH PREPARATION OF CORNEAL ENDOTHELIAL ALLOGRAFT
    65785IMPLANTATION OF INTRASTROMAL CORNEAL RING SEGMENTS
    inv-08: Minimum corneal thickness for CXL
    Minimum corneal thickness for CXL>= 400 microns at time of treatment
    ContextRequired along with diagnosis of progressive keratoconus and evidence of progression within the preceding 12 months
    Consequence of not meetingCXL when corneal thickness is <400 microns would not meet the policy's reasonable and necessary conditions
    inv-09: Minimum corneal thickness at proposed incision site for INTACS
    Minimum corneal thickness at proposed incision site for INTACS>= 450 microns
    ContextRequired in addition to age >=21, progressive keratoconus, inadequate correction with glasses/contacts, and clear central cornea

    Preauthorization and Documentation Requirements

    Prior Authorization

    Obtain preauthorization for keratoplasty and related corneal procedures

    Preauthorization is required for keratoplasty and related corneal procedures; requests must meet the listed clinical criteria for the specific procedure. Covered CPT codes include 0402T and the 6571x–6578x series listed in the policy and should be included with the authorization request.

    • Preauthorization required for keratoplasty and related corneal procedures
    • Include applicable CPT code(s) from policy (e.g., 0402T, 65710, 65730, 65750, 65755, 65756, 65757, 65785)
    Step Therapy

    Document prior treatments and failure or contraindication before DALK/PK (and INTACS conditions)

    Other, less-invasive treatments must have failed or be contraindicated before proceeding to DALK or penetrating keratoplasty; similarly, INTACS is covered only when corneal transplantation is the only alternative to improve vision.

    • DALK: "Other treatment options (eg. conventional CXL, Intacs) have failed or are not indicated."

    Background and Clinical Context

    Keratoplasty encompasses a range of corneal transplant and restorative procedures intended to restore vision, relieve pain, and preserve ocular integrity in advanced corneal disease. Modern practice favors layer-specific (lamellar) approaches when feasible — for example, Deep Anterior Lamellar Keratoplasty (DALK) to replace anterior stromal disease while preserving a healthy endothelium — because lamellar techniques reduce rejection risk and can improve outcomes. Full-thickness penetrating keratoplasty (PK) is reserved for cases with full-thickness pathology or when less invasive options have failed or are not indicated. Preoperative selection should prioritize the least invasive effective procedure and document why alternatives (e.g., conventional CXL, INTACS, DALK) are unsuitable or have failed when proceeding to lamellar or penetrating transplantation.

    Definitions of Procedures

    inv-16: Penetrating keratoplasty (PK)
    DefinitionPenetrating keratoplasty (PK) is full-thickness corneal transplantation reserved for full-thickness pathology or complex cases involving multiple corneal layers.
    IndicationsUsed for conditions refractory to less invasive therapies, including full-thickness disease, trauma, infectious keratitis with scarring, or when other options have failed or are not indicated.
    Procedure selectionConsidered when layer-specific techniques (e.g., DALK, endothelial keratoplasty) are not appropriate or have failed
    inv-17: Deep Anterior Lamellar Keratoplasty (DALK)
    DefinitionDeep anterior lamellar keratoplasty (DALK) is a layer-specific transplantation replacing anterior stromal disease while preserving the patient’s endothelium.
    Preferred usage

    Policy Revision History

    2026-06-01Original effective dateLatest

    Policy became effective as written on 2026-06-01.

    2026-03-25Last review

    Policy underwent review on 2026-03-25.

    2027-02-03Next review scheduled

    Next policy review scheduled for 2027-02-03.

    Policy Summary
    PayerBlue Cross Blue Shield - Nebraska
    PolicyMA Keratoplasty (Preauthorization Required)
    Policy CodePolicy M.62
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Last ReviewFeb 3, 2026
    Next Review DateFeb 3, 2027
    Key ActionObtain preauthorization and document diagnosis, objective progression measures, corneal thickness, prior therapies, and relevant procedure codes.
    SourceLink
    On This Page
    Coverage Criteria for Corneal ProceduresCoding and ThresholdsPreauthorization and Documentation RequirementsBackground and Clinical ContextDefinitions of ProceduresPolicy Revision History
    Procedure implicationMeasurement must be at the proposed incision site
    inv-10: Minimum age for INTACS
    Minimum patient age for INTACS>= 21 years
    ContextAge requirement is one of multiple criteria including progressive keratoconus and inadequate vision correction with glasses/contacts
    Coverage notePatient must be 21 years of age or older to meet INTACS criteria
  1. PK: "Other treatment options (eg. conventional CXL, Intacs, DALK) have failed or are not indicated."
  2. INTACS: covered only when "Corneal transplantation is the ONLY alternative to intrastromal corneal ring segments for improving vision."
  3. Documentation Required

    Include required clinical documentation with preauthorization

    Include objective clinical documentation with preauthorization requests: diagnosis, measures of progression, corneal thickness at proposed treatment time/site, prior therapies and outcomes, and the CPT code(s) being requested.

    • Diagnosis (e.g., progressive keratoconus) and specific procedure requested
    • Objective evidence of progression within preceding 12 months (e.g., increase ≥1.00 D in steepest keratometry, mean keratometry increase ≥0.7 D, pachymetry thinning ≥10 microns, reduction in VA >1 line, or prior keratoconus surgical treatment)
    • Corneal pachymetry: ≥400 microns at time of CXL; ≥450 microns at proposed INTACS incision site
    • Clear central cornea when required by procedure
    • Prior therapies attempted and outcomes (e.g., CXL, INTACS, contact lens/GL correction attempts)
    • Applicable CPT code(s) from policy (e.g., 0402T, 65710, 65730, 65750, 65755, 65756, 65757, 65785)
    Denial Risk

    Denial risk if medical necessity criteria are not met

    Requests that do not meet the policy's medical necessity criteria are likely to be denied—examples include CXL without documented progression or insufficient pachymetry, INTACS when transplantation is not the only alternative, or keratoplasty when prior treatments have not failed and are indicated.

    • CXL denials: lack of documented progressive keratoconus within prior 12 months or corneal thickness <400 microns at time of treatment
    • INTACS denials: patient <21 years, inadequate documentation of progressive vision deterioration, inadequate trial of non-surgical correction, or when corneal transplantation is not the only alternative
    • DALK/PK denials: absence of documentation that other treatment options have failed or are not indicated
    Preferred for stromal disease with intact endothelium to preserve immune privilege and reduce rejection risk; indicated when disease involves the anterior ~95% of corneal thickness with normal endothelium.
    PrerequisiteOther treatment options (e.g., conventional CXL, INTACS) must have failed or be not indicated before DALK is considered reasonable and necessary
    inv-18: Corneal collagen cross-linking (CXL)
    DefinitionCorneal collagen cross-linking (CXL) is a procedure to strengthen the corneal stroma to slow or halt progression of keratoconus.
    IndicationIndicated for progressive keratoconus with documented objective evidence of progression within the preceding 12 months (e.g., increase in steepest keratometry >=1.00 D, mean K increase >=0.7 D, pachymetry thinning >=10 microns, decreased visual acuity).
    RequirementsMust have clear central cornea and minimum corneal thickness of >=400 microns at time of treatment to meet policy criteria